Abstract Glucagon-like peptide-1 (GLP-1) analogs, originally developed as antidiabetic agents, have emerged as groundbreaking drugs for treating obesity, following reports of their remarkable weight-reducing effects
If you lose 50 pounds on tirzepatide and regain 35 of them within a year of stopping, the long-term value diminishes substantially
March 2025: The plaintiffs in the Ozempic MDL have filed a response to defendants motion from January to dismiss cases
This included four entirely new plans: Noom + HRT, Microdose GLP-1 Rx Program, Proactive Health Microdose GLP-1 Rx Program, and Diabetes Management (for health plan and employer populations)
adults live with obesity today
Mistake 1: Injecting cold medication We covered this above, but it bears repeating because it is the most common cause of injection pain